Open PAR-25-091 CFDA 93.847 Discretionary

Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)

Posted by National Institutes of Health

Opportunity snapshot. This Grants.gov announcement — Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) — is cataloged under number PAR-25-091 and tied to CFDA assistance listing 93.847, posted by National Institutes of Health. Grants.gov currently shows the opportunity as open, first posted on January 10, 2025. The funding category is Discretionary, delivered as a grant.

Award economics. The award range on file is Up to $75,000. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. Applications close on January 7, 2028 — roughly 581 days from today. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully — federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed — it helps clarify scope and scoring priorities.

Award Range

Up to $75,000

Close Date

January 7, 2028

Posted

January 10, 2025

Instrument

Grant

Description

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) announces a program that provides NIDDK-supported K01, K08, K23, and K25 recipients the opportunity to apply for Small Grant (R03) support at some point during the latter years of their award period of their K award. Through the use of this mechanism, the NIDDK is seeking to enhance the capability of its K01, K08, K23, and K25 award recipients to conduct research as they complete their transition to fully independent investigator status. The R03 grant mechanism supports different types of projects, including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is, therefore, intended to support research projects that can be carried out in a short period of time with limited resources and that may provide preliminary data to support a subsequent R01, or equivalent, application.

Eligibility

00;01;02;04;05;06;07;08;11;12;13;20;22;23;25

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Parent Grant Program

CFDA 93.847

Diabetes, Endocrine, and Metabolic Disease Research

National Institutes of Health

View program →

Agency Contact

NIH Grants Information<br/>grantsinfo@nih.gov

Key Dates

Posted January 10, 2025
Close Date January 7, 2028
Archive Date February 12, 2028
Last Updated January 10, 2025

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)", offered by National Institutes of Health. It is associated with CFDA program 93.847. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) announces a program that provides NIDDK-supported K01, K08, K23, and K25 recipients the opportunity to apply for Small Gran...
Is this opportunity still open?
Yes, this opportunity is currently open for applications. The closing date is January 7, 2028.
How much funding is available?
The award range for this opportunity is Up to $75,000.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

More from National Institutes of Health

Open Closes November 2, 2028

Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)

View →
Open Closes November 2, 2028

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)

View →
Open Closes November 2, 2028

Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)

View →
Open Closes January 25, 2028

Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)

View →
Open Closes March 5, 2029

Research Grants in Clinical Informatics (R01 Clinical Trial Optional)

View →

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Read our methodology — how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainGrants Editorial